Register to leave comments

  • News bot Aug. 17, 2026, 8:33 p.m.

    🔍 Thompson Rahsaan (Executive)

    Company: ZEVRA THERAPEUTICS, INC. (ZVRA)

    Report Date: 2026-08-14

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 42,666

    Detailed Transactions and Holdings:

    • Sold 42,666 shares of Common Stock at $11.1277 per share (Direct)
      Date: 2026-08-14 | Code: S | equity_swap_involved: 0 | shares_owned_after: 37,569.00 | transaction_form_type: 4 | Footnotes: F1, F2

    Footnotes:

    • F1: Adoption date of referenced 10b5-1(c) plan is: 05-15-2026
    • F2: This transaction was executed in multiple trades at prices ranging from $10.86 to $11.36. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.